Royce & Associates’s Houlihan Lokey HLI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.09M Sell
30,495
-6,184
-17% -$912K 0.03% 529
2026
Q1
$5.27M Sell
36,679
-11,622
-24% -$1.91M 0.05% 456
2025
Q4
$8.41M Sell
48,301
-4,941
-9% -$907K 0.09% 360
2025
Q3
$10.9M Sell
53,242
-21,223
-29% -$4.16M 0.11% 277
2025
Q2
$13.4M Sell
74,465
-2,549
-3% -$428K 0.14% 228
2025
Q1
$12.4M Sell
77,014
-22,154
-22% -$3.81M 0.13% 233
2024
Q4
$17.2M Sell
99,168
-23,288
-19% -$4.1M 0.16% 182
2024
Q3
$19.4M Sell
122,456
-27,226
-18% -$4.07M 0.18% 164
2024
Q2
$20.2M Sell
149,682
-10,847
-7% -$1.42M 0.19% 152
2024
Q1
$20.6M Sell
160,529
-48,105
-23% -$5.95M 0.18% 159
2023
Q4
$25M Sell
208,634
-57,542
-22% -$6.24M 0.23% 126
2023
Q3
$28.5M Buy
266,176
+29,737
+13% +$3.07M 0.29% 89
2023
Q2
$23.2M Sell
236,439
-9,000
-4% -$814K 0.23% 116
2023
Q1
$21.5M Buy
245,439
+30,700
+14% +$2.89M 0.21% 121
2022
Q4
$18.7M Buy
214,739
+40,425
+23% +$3.63M 0.2% 138
2022
Q3
$13.1M Sell
174,314
-56,946
-25% -$4.61M 0.15% 198
2022
Q2
$18.3M Buy
231,260
+31,163
+16% +$2.61M 0.19% 140
2022
Q1
$17.6M Sell
200,097
-9,279
-4% -$955K 0.15% 192
2021
Q4
$21.7M Sell
209,376
-137,913
-40% -$14.7M 0.16% 173
2021
Q3
$32M Sell
347,289
-175,846
-34% -$15.4M 0.24% 100
2021
Q2
$42.8M Sell
523,135
-68,926
-12% -$4.99M 0.29% 75
2021
Q1
$39.4M Buy
592,061
+60,994
+11% +$4.12M 0.26% 88
2020
Q4
$35.7M Buy
531,067
+21,350
+4% +$1.38M 0.3% 73
2020
Q3
$30.1M Sell
509,717
-184,260
-27% -$10.6M 0.32% 73
2020
Q2
$38.6M Sell
693,977
-126,144
-15% -$7.35M 0.43% 50
2020
Q1
$42.7M Sell
820,121
-126,973
-13% -$6.58M 0.58% 31
2019
Q4
$46.3M Sell
947,094
-41,124
-4% -$1.94M 0.41% 55
2019
Q3
$44.6M Buy
988,218
+405,069
+69% +$17.9M 0.41% 55
2019
Q2
$26M Sell
583,149
-232,830
-29% -$10.9M 0.23% 100
2019
Q1
$37.4M Sell
815,979
-136,701
-14% -$6.03M 0.32% 72
2018
Q4
$35.1M Buy
952,680
+226,952
+31% +$9.25M 0.31% 73
2018
Q3
$32.6M Buy
725,728
+169,558
+30% +$8.22M 0.22% 100
2018
Q2
$28.5M Sell
556,170
-15,600
-3% -$746K 0.2% 129
2018
Q1
$25.5M Sell
571,770
-160,400
-22% -$7.59M 0.18% 144
2017
Q4
$33.3M Sell
732,170
-178,999
-20% -$7.66M 0.22% 110
2017
Q3
$35.7M Sell
911,169
-327,867
-26% -$12M 0.24% 104
2017
Q2
$43.2M Sell
1,239,036
-389,812
-24% -$13.2M 0.29% 81
2017
Q1
$56.1M Buy
1,628,848
+395,001
+32% +$12.6M 0.37% 61
2016
Q4
$38.4M Buy
1,233,847
+922,500
+296% +$25M 0.25% 115
2016
Q3
$7.8M Buy
+311,347
New +$7.51M 0.05% 452

Other funds holding HLI

Royce & Associates's HLI Position: Q2 2026 in Review

Royce & Associates reduced its Houlihan Lokey (HLI) stake by 17% in Q2 2026, selling an estimated $912K and leaving 30,495 shares worth $4.09M. The position accounts for 0.03% of the portfolio, ranked #529.

Royce & Associates first reported a position in HLI in Q3 2016 and has held it in 40 quarters since. The position peaked at $56.1M in Q1 2017. 514 funds tracked by Wall St. Rank hold HLI as of Q2 2026.

  • Royce & Associates held 30,495 shares of Houlihan Lokey worth $4.09M as of Q2 2026.
  • Royce & Associates sold 6,184 Houlihan Lokey shares in Q2 2026, an estimated $912K.
  • Houlihan Lokey made up 0.03% of Royce & Associates's portfolio in Q2 2026, its #529 holding.
  • Royce & Associates first reported a position in Houlihan Lokey in Q3 2016 and has held it in 40 quarters since.
  • Royce & Associates's Houlihan Lokey position peaked at $56.1M in Q1 2017.
  • 514 funds tracked by Wall St. Rank held Houlihan Lokey as of Q2 2026.

Based on Royce & Associates's 13F filing for Q2 2026, filed 14 Aug 2026.